G protein-coupled estrogen receptor (GPER) that is implicated in FASN modulation can suppress CRC progression, despite some controversial studies reporting a promoting role of GPER in CRC (Santolla et al., 2012 .; Gilligan et al., 2017). Here, GPER1 is linked to colorectal carcinoma.